Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Junshida (ongericimab)
i
Other names:
JS002
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Chongqing Bochuang Pharmaceuticals, Shanghai Junshi Biosci
Drug class:
PCSK9 inhibitor
Related drugs:
‹
PF-06446846 (1)
evolocumab (1)
alirocumab (0)
PF-06446846 (1)
evolocumab (1)
alirocumab (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.